Articles in Scholarly Journals [Incomplete List]

1. Cancer Chemoprevention and Cancer Preventive Vaccines--A Call to Action: Leaders of Diverse Stakeholder Groups Present Strategies for Overcoming Multiple Barriers to Meet an Urgent Need
   Cancer Research, vol. 66, no. 24, pp. 11540–11549, 2006
2. Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer
   Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 4, pp. 981–987, 2005
3. Natural killer-dendritic cell cross-talk in cancer immunotherapy
   Expert Opinion on Biological Therapy, vol. 5, no. 10, pp. 1303–1315, 2005
4. IL-18-induced CD83+CCR7+ NK helper cells
   Journal of Experimental Medicine, vol. 202, no. 7, pp. 941–953, 2005
5. Immunologic Aspects of Chronic Fatigue Syndrome
   Neuroimmunomodulation, vol. 11, no. 6, pp. 351–357, 2004
6. A novel epitope of N-CAM defines precursors of human adherent NK cells
   Journal of Leukocyte Biology, vol. 76, no. 6, pp. 1187–1199, 2004
7. Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases
   International Journal of Cancer, vol. 105, no. 4, pp. 512–519, 2003
8. Allelic polymorphisms in the FcγRIIC gene can influence its function on normal human natural killer cells
   Journal of Molecular Medicine, vol. 80, no. 4, pp. 248–257, 2002
9. Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice
   Journal of Experimental Therapeutics and Oncology, vol. 2, no. 6, pp. 337–349, 2002
10. Cancer immunotherapy with natural killer cells
    Seminars in Oncology, vol. 29, no. 3, pp. 27–30, 2002
11. Cancer Immunotherapy with Interleukin-2-Activated Natural Killer Cells
    Molecular Biotechnology, vol. 21, no. 2, pp. 161–170, 2002
12. Journal of Immunotherapy, vol. 24, no. 6, pp. 472–481, 2001
13. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay
    Journal of Immunological Methods, vol. 253, no. 1-2, pp. 69–81, 2001
14. Erratum to “Role of natural killer cells and T cells in immune surveillance” [Leukemia Research 24 (2000) 775]
    Leukemia Research, vol. 25, no. 1, p. 101, 2001
15. Role of natural killer cells and T cells in immune surveillance
    Leukemia Research, vol. 24, no. 9, p. 775, 2000
16. Expression of murine CD34 by fetal liver NK cell progenitors
    Experimental Hematology, vol. 27, no. 2, pp. 272–281, 1999
17. Characterization of the stage in natural killer cell development in 14.5-day mouse fetal liver using adult bone marrow stroma
    Experimental Hematology, vol. 27, no. 6, pp. 1046–1056, 1999
18. Ligand binding specificities and signal transduction pathways of Fc? receptor IIc isoforms: the CD32 isoforms expressed by human NK cells
    European Journal of Immunology, vol. 29, no. 9, pp. 2842–2852, 1999
19. Dysfunction of Natural Killer Activity in a Family with Chronic Fatigue Syndrome
    Clinical Immunology and Immunopathology, vol. 88, no. 1, pp. 96–104, 1998
20. Methionine Enkephalin: A New Cytokine—Human Studies
    Clinical Immunology and Immunopathology, vol. 82, no. 2, pp. 93–101, 1997
21. Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma
    Cancer Immunology, Immunotherapy, vol. 44, no. 3, pp. 137–149, 1997
22. T-cell homeostasis in HIV infection is neither failing nor blind: Modified cell counts reflect an adaptive response of the host
    Nature Medicine, vol. 3, no. 5, Article ID nm0597-486, 4 pages, 1997
23. Mathematical models of HIV pathogenesis
    Nature Medicine, vol. 3, no. 9, Article ID nm0997-936a, 1 pages, 1997
24. Effect of Influenza A Virus Infection on Natural and Adaptive Cellular Immunity
    Clinical Immunology and Immunopathology, vol. 79, no. 3, pp. 294–302, 1996
25. Antitumor Functions of Natural Killer Cells and Control of Metastases
    Methods, vol. 9, no. 2, pp. 394–408, 1996
26. Divergent Phosphotyrosine Signaling via Fc?RIIIA on Human NK Cells
    Cellular Immunology, vol. 167, no. 1, pp. 63–71, 1996
27. Divergent effects of Fc?RIIIA ligands on the functional activities of human natural killer cellsin vitro
    European Journal of Immunology, vol. 26, no. 6, pp. 1199–1203, 1996
28. Phase II Trial of Interferon-?? in Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Immunological and Clinical Correlates
    Journal of Immunotherapy, vol. 19, no. 6, pp. 433–442, 1996
29. Divergent Effects of H-2K and H-2D Genes on Sensitivity of BL6 Melanoma Cells to NK Cells or TNF-Mediated Cytotoxicity
    Cellular Immunology, vol. 155, no. 2, pp. 358–371, 1994
30. To the editor
    World Journal of Surgery, vol. 18, no. 3, pp. 442–442, 1994
31. Surface aminopeptidase activity of rat natural killer cells I. Biochemical and biological properties
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1221, no. 3, pp. 221–232, 1994
32. 15Cr-labeled human hepatocytes as target cells for cytotoxicity mediated by freshly isolated liver-infiltrating lymphocytes
    Journal of Immunological Methods, vol. 164, no. 1, pp. 69–77, 1993
33. In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment
    European Journal of Cancer, vol. 29, no. 3, pp. 371–377, 1993
34. Effects of Adoptive Immunotherapy with Autologous CD8+ T Lymphocytes on Immunologic Parameters: Lymphocyte Subsets and Cytotoxic Activity
    Clinical Immunology and Immunopathology, vol. 68, no. 3, pp. 263–272, 1993
35. From HIV Infection to AIDS: Are the Manifestations of Effective Immune Resistance Misinterpreted?
    Clinical Immunology and Immunopathology, vol. 69, no. 2, pp. 123–135, 1993
36. Low NK Syndrome and Its Relationship to Chronic Fatigue Syndrome
    Clinical Immunology and Immunopathology, vol. 69, no. 3, pp. 253–265, 1993
37. Degradation of Enkephalins by Rat Lymphocyte and Purified Rat Natural Killer Cell Surface Aminopeptidases
    Brain, Behavior, and Immunity, vol. 7, no. 2, pp. 176–187, 1993
38. Regulation of Human Natural Cytotoxicity by IgG IV. Association between Binding of Monomeric LgG to the Fc Receptors on Large Granular Lymphocytes and Inhibition of Natural Killer (NK) Cell Activity
    Cellular Immunology, vol. 147, no. 2, pp. 397–410, 1993
39. Distinct Phenotypic and Functional Characteristics of Human Natural Killer Cells Obtained by Rapid Interleukin 2-Induced Adherence to Plastic
    Cellular Immunology, vol. 151, no. 1, pp. 133–157, 1993
40. Differential Effects of IL12 and IL2 on Expression and Function of Cellular Adhesion Molecules on Purified Human Natural Killer Cells
    Cellular Immunology, vol. 152, no. 2, pp. 481–498, 1993
41. Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels
    Cancer Immunology Immunotherapy, vol. 34, no. 4, pp. 221–227, 1992
42. Reply to the Letter to the editors by A. Maghazachi
    Cancer Immunology Immunotherapy, vol. 35, no. 6, pp. 428–430, 1992
43. Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease
    Hepatology, vol. 15, no. 5, pp. 816–823, 1992
44. Tumor-infiltrating lymphocytes Potential and limitations to their use for cancer therapy
    Critical Reviews in Oncology/Hematology, vol. 12, no. 1, pp. 25–47, 1992
45. Gene Amplification and Gene Dosage in Cell Lines Derived From Squamous Cell Carcinoma of the Head and Neck
    Genes, Chromosomes and Cancer, vol. 3, no. 6, pp. 443–454, 1991
46. Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors
    Cancer Immunology Immunotherapy, vol. 32, no. 5, pp. 280–288, 1991
47. Induction of tumor regression in experimental model of human head and neck cancer by human a-lak cells and IL-2
    International Journal of Cancer, vol. 47, no. 5, pp. 784–791, 1991
48. Depressed Ability of Patients with Melanoma or Renal Cell Carcinoma to Generate Adherent Lymphokine-Activated Killer Cells
    Journal of Immunotherapy, vol. 10, no. 5, pp. 336–346, 1991
49. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases
    Journal of Experimental Medicine, vol. 174, no. 2, pp. 479–488, 1991
50. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells
    Journal of Experimental Medicine, vol. 169, no. 4, pp. 1373–1389, 1989
51. Lymphokine-activated killer cell activity in patients with primary and metastatic malignant liver tumors
    Hepatology, vol. 10, no. 2, pp. 221–227, 1989
52. Functional and phenotypic analysis of tumor-infiltrating. Lymphocytes isolated from human primary and metastatic. Liver tumors and cultured in recombinant interleukin-2
    Cancer, vol. 63, no. 1, pp. 102–111, 1989
53. In vitro effects of an acyltripeptide, FK565, on NK-cell activity, LAK-cell generation and cytokine production by human mononuclear cells
    Immunopharmacology, vol. 17, no. 3, pp. 175–185, 1989
54. Up-regulation of natural killer activity of human immunodeficiency virus-infected patients by in vitro-differentiated macrophages
    Clinical Immunology and Immunopathology, vol. 51, no. 1, pp. 133–139, 1989
55. Lymphokine-activated killer cells in rats: Generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells
    Cellular Immunology, vol. 118, no. 2, pp. 448–457, 1989
56. Proliferative effects of 12--Tetradecanoylphorbol-13-acetate (TPA) and calcium ionophores on human large granular lymphocytes (LGL)
    Cellular Immunology, vol. 113, no. 1, pp. 70–81, 1988
57. distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells
    Cellular Immunology, vol. 115, no. 1, pp. 179–194, 1988
58. Regulation of human natural cytotoxicity by IgG II. Cyclic AMP as a mediator of monomeric IgG-induced inhibition of natural killer cell activity
    Cellular Immunology, vol. 114, no. 2, pp. 246–256, 1988
59. Differential in vitro modulation of suppressor and antitumor functions of mouse macrophages by lymphokines and/or endotoxin
    Cellular Immunology, vol. 114, no. 2, pp. 282–292, 1988
60. Lymphokine-activated killer cells: analysis of their anti-tumour efficacy in vitro and in vivo
    Annales de l'Institut Pasteur. Immunologie, vol. 139, no. 4, pp. 466–471, 1988
61. Role of interferons in natural killer cell generation from primitive bone marrow precursors
    International Journal of Immunopharmacology, vol. 10, no. 6, pp. 665–673, 1988
62. Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells
    Journal of Experimental Medicine, vol. 167, no. 1, pp. 15–29, 1988
63. Inhibition of Pluripotent Hematopoietic Stem Cells of Bone Marrow by Large Granular Lymphocytes
    Proceedings of the National Academy of Sciences, vol. 84, no. 21, pp. 7691–7695, 1987
64. Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen
    Immunology Today, vol. 8, no. 6, pp. 178–181, 1987
65. Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors
    Leukemia Research, vol. 11, no. 12, pp. 1059–1066, 1987
66. Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity
    Clinical & Experimental Metastasis, vol. 5, no. 1, pp. 43–56, 1987
67. Low frequency of NK-cell progenitors and development of suppressor cells in IL-2-dependent cultures of spleen cells from low NK-reactive SJL/J mice
    International Journal of Cancer, vol. 38, no. 1, pp. 117–125, 1986
68. ?Immune surveillance? without immunogenicity
    Immunology Today, vol. 7, no. 5, pp. 128–131, 1986
69. Natural killer cells in lungs and other tissues and regulation of their activity by suppressor cells
    Journal of Allergy and Clinical Immunology, vol. 78, no. 4, pp. 566–570, 1986
70. Characterization of cell lines enhancing IL-2 production by human phytohemagglutinin-stimulated lymphocytes
    Cellular Immunology, vol. 90, no. 1, pp. 142–153, 1985
71. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters.
    Health Psychology, vol. 4, no. 2, Article ID 1986-12232-001, 14 pages, 1985
72. Lack of gene rearrangement and mRNA expression of the beta chain of the T cell receptor in spontaneous rat large granular lymphocyte leukemia lines
    Journal of Experimental Medicine, vol. 161, no. 5, pp. 1249–1254, 1985
73. A Species of Human alpha Interferon That Lacks the Ability to Boost Human Natural Killer Activity
    Proceedings of the National Academy of Sciences, vol. 81, no. 15, pp. 4926–4929, 1984
74. Production of plasminogen activator by human natural killer cells. Large granular lymphocytes
    Journal of Experimental Medicine, vol. 159, no. 3, pp. 935–951, 1984
75. Inhibition of activity of human NK and K cells by simple sugars: Discrimination between binding and postbinding events
    Clinical Immunology and Immunopathology, vol. 31, no. 3, pp. 439–443, 1984
76. Role of nk cells in the antimetastatic effect of anticoagulant drugs
    International Journal of Cancer, vol. 33, no. 1, pp. 87–94, 1984
77. Cloned lines of SJL/J spleen cells with cytotoxic reactivity
    International Journal of Cancer, vol. 31, no. 3, pp. 345–350, 1983
78. Interferon-independent, lectin-induced augmentation of murine natural killer cell activity
    International Journal of Cancer, vol. 29, no. 3, pp. 299–307, 1982
79. Isolation of human and rat natural killer cells
    Journal of Immunological Methods, vol. 51, no. 3, pp. 269–277, 1982
80. Dual effect of interferons on IL-2 induced proliferation of human T cells and large granular lymphocytes (NK) assessed by limiting dilution analysis
    International Journal of Immunopharmacology, vol. 4, no. 4, p. 254, 1982
81. Immunoregulation and natural killer cells
    Molecular Immunology, vol. 19, no. 10, pp. 1313–1321, 1982
82. Effect of various immunoregulatory substances on the growth inhibitory activity (GIA) of human monocytes against lymphoblastoid cell lines
    Immunopharmacology, vol. 4, no. 2, pp. 105–113, 1982
83. The effect of lentinan on production of interleukin-1 by human monocytes
    Immunopharmacology, vol. 5, no. 1, pp. 65–74, 1982
84. Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes
    Cellular Immunology, vol. 67, no. 1, pp. 160–167, 1982
85. A rapid technique for isolation of viable tumor cells from solid tumors: Use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses
    European Journal of Cancer and Clinical Oncology, vol. 18, no. 10, pp. 991–1000, 1982
86. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells
    Journal of Experimental Medicine, vol. 153, no. 3, pp. 569–582, 1981
87. Production of both macrophage activating and inhibiting activities by a murine T-lymphocyte hybridoma
    Nature, vol. 291, no. 5815, Article ID 291502a0, 1 pages, 1981
88. reactivity of mouse natural killer (NK) cells against normal bone marrow cells
    Cellular Immunology, vol. 60, no. 1, pp. 136–143, 1981
89. Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon
    Journal of Clinical Immunology, vol. 1, no. 3, pp. 149–153, 1981
90. Lymphoproliferative responses to autologous tumor extracts as prognostic indicators in patients with resected breast cancer
    International Journal of Cancer, vol. 27, no. 2, pp. 131–138, 1981
91. Antibody-induced augmentation of murine natural killer cell activity
    International Journal of Cancer, vol. 27, no. 2, pp. 205–211, 1981
92. Systemic andin situ natural killer and suppressor cell activities in mice bearing progressively growing murine sarcoma-virus-induced tumors
    International Journal of Cancer, vol. 27, no. 2, pp. 243–248, 1981
93. Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer
    International Journal of Cancer, vol. 27, no. 5, pp. 569–576, 1981
94. Radioisotope assay for evaluation ofin vivo natural cell-mediated resistance of mice to local transplantation of tumor cells
    International Journal of Cancer, vol. 27, no. 5, pp. 709–720, 1981
95. Cytostasis of tumor cell lines by granulocytes from cancer patients and normal human donors
    International Journal of Cancer, vol. 28, no. 2, pp. 119–124, 1981
96. In vivo anti-tumor effects of local adoptive transfer of mouse and human cultured lymphoid cells
    International Journal of Cancer, vol. 28, no. 2, pp. 157–164, 1981
97. Association of depressed postoperative lymphoproliferative responses to alloantigens with poor prognosis in patients with stage I lung cancer
    International Journal of Cancer, vol. 25, no. 1, pp. 9–17, 1980
98. Cytotoxic effector cells with the characteristics of natural killer cells in the lungs of mice
    International Journal of Cancer, vol. 25, no. 1, pp. 153–158, 1980
99. Augmentation of tumoricidal activity of human monocytes and macrophages by lymphokines
    International Journal of Cancer, vol. 25, no. 6, pp. 691–699, 1980
100. Species-restricted effects of human and mouse lymphokines on macrophages
     European Journal of Immunology, vol. 10, no. 7, pp. 542–546, 1980
101. Lack of expression on cultured human T-lymphocytes of a T-cell antigen shared by the molt-4 cell line and normal human thymocytes
     In Vitro, vol. 16, no. 9, pp. 754–760, 1980
102. â??High-affinityâ? t-cell rosettes: The effects of clinical manipulations and potential prognostic significance
     Journal of Surgical Oncology, vol. 13, no. 2, pp. 145–153, 1980
103. Augmentation of human monocyte-mediated cytolysis by interferon
     Cellular Immunology, vol. 54, no. 2, pp. 425–434, 1980
104. Cytostasis of tumor cell lines by human granulocytes
     Cellular Immunology, vol. 53, no. 1, pp. 104–115, 1980
105. Depletion of monocytes from human peripheral blood mononuclear leukocytes: Comparison of the sephadex G-10 column method with other commonly used techniques
     Journal of Immunological Methods, vol. 32, no. 1, pp. 11–29, 1980
106. Enzyme-linked immunosorbent assay for screening monoclonal antibody production: Use of intact cells as antigen
     Journal of Immunological Methods, vol. 39, no. 4, pp. 309–316, 1980
107. Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo
     Journal of Experimental Medicine, vol. 151, no. 4, pp. 781–789, 1980
108. ROLE OF INTERFERON IN REGULATION OF CYTOTOXICITY BY NATURAL KILLER CELLS AND MACROPHAGES
     Annals of the New York Academy of Sciences, vol. 350, no. 1 Regulatory Fu, pp. 63–71, 1980
109. Natural Killer Cells: Characteristics and Regulation of Activity
     Immunological Reviews, vol. 44, no. 1, pp. 43–70, 1979
110. Variation among mouse strains in responsiveness to migration inhibitory factor
     Cellular Immunology, vol. 45, no. 2, pp. 464–468, 1979
111. Cytolytic and cytostatic activity on tumor cells of circulating human monocytes
     International Journal of Cancer, vol. 23, no. 1, pp. 18–27, 1979
112. Suppression of lymphokine production by macrophages infiltrating murine virus-induced tumors
     International Journal of Cancer, vol. 24, no. 1, pp. 97–102, 1979
113. Immunological study of two stocks of moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice
     International Journal of Cancer, vol. 21, no. 1, pp. 78–84, 1978
114. Natural cell-mediated cytotoxicity in rats. I. Tissue and strain distribution, and demonstration of a membrane receptor for the Fc portion of IgG
     International Journal of Cancer, vol. 21, no. 2, pp. 204–209, 1978
115. Natural cell-mediated cytotoxicity in rats. III. Effects of immunopharmacologic treatments on natural reactivity and on reactivity augmented by polyinosinic-polycytidylic acid
     International Journal of Cancer, vol. 21, no. 2, pp. 221–229, 1978
116. Relationship between T lymphocyte levels and lymphoproliferative responses to mitogens and alloantigens in lung and breast cancer patients
     International Journal of Cancer, vol. 21, no. 3, pp. 282–290, 1978
117. Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells
     International Journal of Cancer, vol. 19, no. 4, pp. 555–564, 1977
118. The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens
     International Journal of Cancer, vol. 20, no. 3, pp. 359–370, 1977
119. Natural cell-mediated cytotoxicity in mice against non-lymphoid tumor cells and some normal cells
     International Journal of Cancer, vol. 20, no. 3, pp. 381–387, 1977
120. Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies.Clinical description
     Cancer, vol. 39, no. 3, pp. 1224–1228, 1977
121. Skin tests with soluble melanoma antigens in patients with choroidal tumors
     Cancer, vol. 40, no. 4, pp. 1650–1654, 1977
122. In vitro inhibition of lymphoproliferative responses to tumor associated antigens and of lymphoma cell proliferation by rat splenic macrophages
     Cellular Immunology, vol. 28, no. 2, pp. 355–370, 1977
123. Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells I. Characteristics of inhibition and evidence for an infectious agent
     Cellular Immunology, vol. 33, no. 2, pp. 364–377, 1977
124. Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells II. Evidence that Kilham rat virus is responsible for the inhibitory effect
     Cellular Immunology, vol. 33, no. 2, pp. 378–391, 1977
125. Inhibition of rat mixed lymphocyte cultures by suppressor macrophages
     Cellular Immunology, vol. 29, no. 2, pp. 238–250, 1977
126. Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: Comparison with the capillary tube assay
     Journal of Immunological Methods, vol. 15, no. 4, pp. 355–371, 1977
127. Cytotoxicity against tumour-associated antigens not H–2 restricted
     Nature, vol. 268, no. 5617, Article ID 268250a0, 2 pages, 1977
128. Two mechanisms of migration inhibition factor induction by tumour antigens
     Nature, vol. 270, no. 5632, Article ID 270062a0, 2 pages, 1977
129. Immunogenicity of tumor antigens
     Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 473, no. 2, pp. 93–119, 1977
130. Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases
     Clinical Immunology and Immunopathology, vol. 5, no. 1, pp. 60–66, 1976
131. Mixed lymphocyte/tumor-cell interaction in a murine sarcoma virus (moloney)-induced tumor system. Comparison between lymphoproliferation and lymphocyte cytotoxicity
     International Journal of Cancer, vol. 17, no. 3, pp. 362–369, 1976
132. Immunological monitoring and immunotherapy in carcinoma of the lung
     International Journal of Cancer, vol. 18, no. 6, pp. 739–749, 1976
133. Inhibition of the mixed lymphocyte culture by peritoneal exudate cells
     Cellular Immunology, vol. 22, no. 2, pp. 399–403, 1976
134. Immune response to gross virus-induced lymphoma cryopreservation of functional activity of rat lymphocytes and tumor cells
     Cellular Immunology, vol. 25, no. 1, pp. 60–73, 1976
135. Participation of three lymphoid cell types in the activation of cell-mediated immunity to a syngeneic gross virus-induced lymphoma in rats
     Cellular Immunology, vol. 23, no. 2, pp. 268–277, 1976
136. IMMUNOGENICITY OF TUMOR ANTIGENS
     Annals of the New York Academy of Sciences, vol. 276, no. 1 International, pp. 26–44, 1976
137. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity
     International Journal of Cancer, vol. 16, no. 2, pp. 216–229, 1975
138. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells
     International Journal of Cancer, vol. 16, no. 2, pp. 230–239, 1975
139. Inhibition ofin vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing gross leukemia virus-induced tumors
     International Journal of Cancer, vol. 16, no. 3, pp. 384–393, 1975
140. Suppression of cell-mediated tumour immunity by Corynebacterium parvum
     Nature, vol. 257, no. 5525, Article ID 257396a0, 2 pages, 1975
141. Specific afferent interference by antiserum of in vivo immunity
     Nature, vol. 257, no. 5529, Article ID 257801a0, 1 pages, 1975
142. EVIDENCE OF SUPPRESSOR CELL ACTIVITY IN SPLEENS OF MICE BEARING PRIMARY TUMORS INDUCED BY MOLONEY SARCOMA VIRUS
     Journal of Experimental Medicine, vol. 139, no. 6, pp. 1473–1487, 1974
143. Soluble membrane antigens of human malignant melanoma cells
     Cancer, vol. 34, no. 4, pp. 1235–1243, 1974
144. A human lymphoid cell line with receptors for both sheep red blood cells and complement
     Cellular Immunology, vol. 14, no. 1, pp. 139–145, 1974
145. Suppression of in vitro lymphocyte stimulation in mice bearing primary moloney sarcoma virus-induced tumors
     Cellular Immunology, vol. 13, no. 1, pp. 32–40, 1974
146. Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia
     International Journal of Cancer, vol. 12, no. 2, pp. 409–419, 1973
147. Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. I. Serological analysis of the antigenic specificities
     International Journal of Cancer, vol. 12, no. 2, pp. 511–518, 1973
148. Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. II. Tumor transplantation studies
     International Journal of Cancer, vol. 12, no. 2, pp. 519–523, 1973